These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2074908)

  • 1. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
    Wollersheim H; Thien T
    Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Raynaud phenomenon in childhood: review and progress control in eight cases].
    González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
    An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
    Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
    Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raynaud's phenomenon: clinical spectrum of 118 patients.
    De Angelis R; Del Medico P; Blasetti P; Cervini C
    Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
    Houtman PM; Kallenberg CG; Fidler V; Wouda AA
    J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients.
    Arpaia G; Cimminiello C; Bellone M; Aloisio M; Rossi F; Bonfardeci G
    Int Angiol; 1994 Mar; 13(1):15-8. PubMed ID: 8077792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser Doppler velocimetry of fingertips during heat provocation in normals and in patients with Raynaud's phenomenon.
    Wollersheim H; Reyenga J; Thien T
    Scand J Clin Lab Invest; 1988 Feb; 48(1):91-5. PubMed ID: 2975399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon as an early sign of connective tissue diseases.
    Kallenberg CG
    Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud's phenomenon and connective tissue diseases].
    Guilmot JL; Diot E; Lasfargues G; Boissier C
    Rev Prat; 1998 Oct; 48(15):1647-52. PubMed ID: 9814065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon.
    Lally EV
    Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
    Chamot AM; Monti M
    Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.